News

HMGB1 is a nuclear DNA-binding protein, which is elevated in the body following infection or trauma and may be an important factor when developing therapeutics to treat these

With the acquisition, Brenntag is expected to get access to an established distribution network active in nine countries with growth potential. EAC Industrial Ingredients holds an important market

Peter Schulz-Knappe, CSO and executive vice president of diagnostics at Protagen, said: “Also classical infectious disease diagnostics can benefit from UNIarray, the proprietary technology platform of Protagen for

Earlier, Dr Glenn was the chief scientific officer and founder of IOMAI Corporation (now Intercell), an associate in international health at Johns Hopkins University’s School of Public Health

Hybrigenics got approval for the launch of Hybrigenics Services SAS subsidiary on June 25, 2010. The company said that this business generated EUR 3.27m revenue in 2009 and

Girindus said that the oligonucleotide product is a single strand phosphorothioate compound which has been granted an orphan drug designation. Girindus stated that the process validation program to

Quintiles said that the UMMC is the first Prime Site in Asia, adding to its existing four other sites located in the US, Europe and Africa. Quintiles claimed

Alnara Pharma’s product Liprotamase is an oral, non-porcine pancreatic enzyme replacement therapy (PERT) designed to treat maldigestion, malabsorption and malnutrition as a result of exocrine pancreatic insufficiency associated

Lexaryn claimed that the male enhancer drug is formulated using natural ingredients like Ashwaganda root, Maca root and Epimedium grandiforum that have been used by herbalists for centuries